naloxone
Commercial- Indications
- Opioid overdose
Company intelligence / Profile preview
Sterinova
Saint-Hyacinthe, Quebec, Canadasterinova.com ↗
- Ownership
- Private
- Employees
- ~66
- Development stage
- Commercial
01
Overview
Sterinova develops, manufactures, and distributes high-quality ready-to-use injectable pharmaceutical products for hospital and pharmacy use. Its portfolio includes commercialized injectables such as heparin sodium prefilled syringes. The company operates under GMP standards with Health Canada licensure since 2015, is FDA-inspected, and serves Canadian as well as international markets.
- Therapeutic areas
- Cardiovascular
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
With Canadian division of B. Braun
Beyond the preview
Go deeper on Sterinova.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sterinova.